Carlos V Paya
CIK 1606244 · View on SEC EDGAR ↗
First SEC filing: Oct. 29, 2021 · Latest: Oct. 29, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 15, 2026 | PCVX | A | 11,389 | — | — | 11,389 Direct | — | Acquired | (price as of 2026-08-21) |
| June 15, 2026 | PCVX | A | 2,265 | — | — | 6,856 Direct | +49.34% | Acquired | (price as of 2026-08-21) |
| May 15, 2025 | COLL | A | 19,582 | — | — | 19,582 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 15,000 | — | — | 15,000 Indirect | — | Acquired | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 15,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 18,750 | — | — | 18,750 Indirect | — | Acquired | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 18,750 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 30,000 | — | — | 30,000 Indirect | — | Acquired | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 30,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | A | 3,125 | — | — | 3,125 Indirect | — | Acquired | (price as of 2026-08-21) |
| Nov. 9, 2023 | PCVX | G | 3,125 | — | — | 2,500 Direct | -55.56% | Disposed | (price as of 2026-08-21) |
| June 14, 2023 | LAB | A | 35,380 | — | — | 35,380 Direct | — | Acquired | (price as of 2026-08-21) |
| June 14, 2023 | LAB | A | 26,376 | — | — | 126,844 Direct | +26.25% | Acquired | (price as of 2026-08-21) |
| June 13, 2023 | PCVX | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 13, 2023 | PCVX | A | 2,500 | — | — | 5,625 Direct | +80.00% | Acquired | (price as of 2026-08-21) |
| June 15, 2022 | LAB | A | 42,571 | — | — | 42,571 Direct | — | Acquired | (price as of 2026-08-21) |
| June 15, 2022 | LAB | A | 30,914 | — | — | 100,468 Direct | +44.45% | Acquired | (price as of 2026-08-21) |
| June 1, 2022 | PCVX | A | 18,750 | — | — | 18,750 Direct | — | Acquired | (price as of 2026-08-21) |
| June 1, 2022 | PCVX | A | 3,125 | — | — | 3,125 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 27, 2021 | PCVX | A | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-21) |
| May 25, 2021 | LAB | A | 15,402 | — | — | 15,402 Direct | — | Acquired | (price as of 2026-08-21) |
| May 25, 2021 | LAB | A | 10,342 | — | — | 69,554 Direct | +17.47% | Acquired | (price as of 2026-08-21) |
| March 23, 2021 | LAB | M | 2,500 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| March 23, 2021 | LAB | M | 2,500 | — | — | 59,212 Direct | +4.41% | Acquired | (price as of 2026-08-21) |
| June 23, 2020 | LAB | A | 20,993 | — | — | 20,993 Direct | — | Acquired | (price as of 2026-08-21) |
| June 23, 2020 | LAB | A | 13,369 | — | — | 56,712 Direct | +30.84% | Acquired | (price as of 2026-08-21) |
| March 23, 2020 | LAB | M | 2,500 | — | — | 2,500 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| March 23, 2020 | LAB | M | 2,500 | — | — | 43,343 Direct | +6.12% | Acquired | (price as of 2026-08-21) |
| June 3, 2019 | LAB | A | 6,796 | — | — | 6,796 Direct | — | Acquired | (price as of 2026-08-21) |
| June 3, 2019 | LAB | A | 3,987 | — | — | 40,843 Direct | +10.82% | Acquired | (price as of 2026-08-21) |
| March 23, 2019 | LAB | M | 2,500 | — | — | 5,000 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| March 23, 2019 | LAB | M | 2,500 | — | — | 36,856 Direct | +7.28% | Acquired | (price as of 2026-08-21) |
| Feb. 12, 2019 | LAB | A | 4,522 | — | — | 34,356 Direct | +15.16% | Acquired | (price as of 2026-08-21) |
| May 31, 2018 | LAB | A | 10,600 | — | — | 10,600 Direct | — | Acquired | (price as of 2026-08-21) |
| May 31, 2018 | LAB | A | 6,100 | — | — | 29,834 Direct | +25.70% | Acquired | (price as of 2026-08-21) |
| May 30, 2018 | LAB | M | 3,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| May 30, 2018 | LAB | M | 5,000 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| May 30, 2018 | LAB | M | 3,000 | — | — | 23,734 Direct | +14.47% | Acquired | (price as of 2026-08-21) |
| May 30, 2018 | LAB | M | 5,000 | — | — | 20,734 Direct | +31.78% | Acquired | (price as of 2026-08-21) |
| March 23, 2018 | LAB | M | 2,500 | — | — | 7,500 Direct | -25.00% | Disposed | (price as of 2026-08-21) |
| March 23, 2018 | LAB | M | 2,500 | — | — | 15,734 Direct | +18.89% | Acquired | (price as of 2026-08-21) |
| Feb. 13, 2018 | LAB | A | 5,952 | — | — | 13,234 Direct | +81.74% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2017 | LAB | M | 3,641 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Dec. 31, 2017 | LAB | M | 3,641 | — | — | 7,282 Direct | +100.00% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2017 | LAB | M | 3,641 | — | — | 3,641 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| Sept. 30, 2017 | LAB | M | 3,641 | — | — | 3,641 Direct | — | Acquired | (price as of 2026-08-21) |
| Sept. 13, 2017 | LAB | A | 3,000 | — | — | 3,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Sept. 13, 2017 | LAB | A | 3,000 | — | — | 3,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 8, 2017 | LAB | A | 7,282 | — | — | 7,282 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 1, 2017 | LAB | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 1, 2017 | LAB | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 23, 2017 | LAB | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 23, 2017 | LAB | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 15, 2026 | PCVX | Stock Option (right to buy) | Common Stock (11,389) | $49.56 | June 15, 2036 | 11,389 | Acquired |
| Nov. 9, 2023 | PCVX | Stock Option (right to buy) | Common Stock (15,000) | $53.08 | June 12, 2033 | 15,000 | Acquired |
| Nov. 9, 2023 | PCVX | Stock Option (right to buy) | Common Stock (15,000) | $53.08 | June 12, 2033 | 15,000 | Disposed |
| Nov. 9, 2023 | PCVX | Stock Option (right to buy) | Common Stock (18,750) | $22.70 | May 31, 2032 | 18,750 | Acquired |
| Nov. 9, 2023 | PCVX | Stock Option (right to buy) | Common Stock (18,750) | $22.70 | May 31, 2032 | 18,750 | Disposed |
| Nov. 9, 2023 | PCVX | Stock Option (right to buy) | Common Stock (30,000) | $22.02 | Oct. 26, 2031 | 30,000 | Acquired |
| Nov. 9, 2023 | PCVX | Stock Option (right to buy) | Common Stock (30,000) | $22.02 | Oct. 26, 2031 | 30,000 | Disposed |
| June 14, 2023 | LAB | Stock Option (Right to Buy) | Common Stock (35,380) | $2.18 | June 14, 2033 | 35,380 | Acquired |
| June 13, 2023 | PCVX | Stock Option (right to buy) | Common Stock (15,000) | $53.08 | June 12, 2033 | 15,000 | Acquired |
| June 15, 2022 | LAB | Stock Option (Right to Buy) | Common Stock (42,571) | $1.86 | June 15, 2032 | 42,571 | Acquired |
| June 1, 2022 | PCVX | Stock Option (right to buy) | Common Stock (18,750) | $22.70 | May 31, 2032 | 18,750 | Acquired |
| Oct. 27, 2021 | PCVX | Stock Option (Right to Buy) | Common Stock (30,000) | $22.02 | Oct. 26, 2031 | 30,000 | Acquired |
| May 25, 2021 | LAB | Stock Option (Right to Buy) | Common Stock (15,402) | $5.56 | May 25, 2031 | 15,402 | Acquired |
| March 23, 2021 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| June 23, 2020 | LAB | Stock Option (Right to Buy) | Common Stock (20,993) | $3.74 | June 23, 2030 | 20,993 | Acquired |
| March 23, 2020 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| June 3, 2019 | LAB | Stock Option (Right to Buy) | Common Stock (6,796) | $13.41 | June 3, 2029 | 6,796 | Acquired |
| March 23, 2019 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| May 31, 2018 | LAB | Stock Option (Right to Buy) | Common Stock (10,600) | $5.57 | May 31, 2028 | 10,600 | Acquired |
| May 30, 2018 | LAB | Restricted Stock Units | Common Stock (3,000) | — | — | 3,000 | Disposed |
| May 30, 2018 | LAB | Restricted Stock Units | Common Stock (5,000) | — | — | 5,000 | Disposed |
| March 23, 2018 | LAB | Restricted Stock Units | Common Stock (2,500) | — | — | 2,500 | Disposed |
| Dec. 31, 2017 | LAB | Restricted Stock Units | Common Stock (3,641) | — | — | 3,641 | Disposed |
| Sept. 30, 2017 | LAB | Restricted Stock Units | Common Stock (3,641) | — | — | 3,641 | Disposed |
| Sept. 13, 2017 | LAB | Stock Option (Right to Buy) | Common Stock (3,000) | $5.44 | Aug. 1, 2027 | 3,000 | Acquired |
| Sept. 13, 2017 | LAB | Restricted Stock Units | Common Stock (3,000) | — | — | 3,000 | Acquired |
| Aug. 8, 2017 | LAB | Restricted Stock Units | Common Stock (7,282) | — | — | 7,282 | Acquired |
| Aug. 1, 2017 | LAB | Common Stock | Common Stock (5,000) | $3.43 | Aug. 1, 2027 | 5,000 | Acquired |
| Aug. 1, 2017 | LAB | Restricted Stock Units | Common Stock (5,000) | — | — | 5,000 | Acquired |
| March 23, 2017 | LAB | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $5.52 | March 23, 2027 | 15,000 | Acquired |
| March 23, 2017 | LAB | Restricted Stock Units | Common Stock (10,000) | — | — | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 29, 2021 | PCVX | No securities owned. | 0 | Direct |